Skip to main content

Table 8 Summary of “other” conditions each representing less than 1.0% of the total sample of patients seeking medical cannabis certification

From: Medical cannabis use in the United States: a retrospective database study

Condition Patients, n (%)
n = 6519
Neuropathic Pain 580 (0.9%)
Spinal Cord Injury/Disease 574 (0.9%)
Glaucoma 480 (0.8%)
Crohn’s Disease 472 (0.8%)
Stress 418 (0.7%)
Multiple Sclerosis 396 (0.6%)
Irritable Bowel Syndrome 364 (0.6%)
Mood Disorders 271 (0.4%)
Acute Pain 253 (0.4%)
Colitis 244 (0.4%)
HIV/AIDS 224 (0.4%)
Opiate Dependence 183 (0.3%)
Scoliosis 156 (0.3%)
Appetite Stimulation 152 (0.2%)
Parkinson’s Disease Symptoms 148 (0.2%)
Hepatitis C 133 (0.2%)
Chemotherapy Induced Nausea 108 (0.2%)
Autism 57 (0.1%)
Cachexia/Wasting Syndrome 56 (0.1%)
Movement Disorder 46 (0.1%)
Anorexia 42 (0.1%)
Obsessive Compulsive Behaviour 41 (0.1%)
Tremors 38 (0.1%)
Alzheimer’s Disease 26 (0.0%)
Bipolar Disorder 25 (0.0%)
Tourette’s Syndrome 10 (0.0%)
Other 1022 (2.0%)
  1. Table 8 reports the “other” conditions reported in Table 5 that each represent less than 1.0% of the total sample. Percentages are given out of the total sample (61,379 patients). There are over 200 unique conditions that were manually entered into the database by clinic staff that are categorized as “Other” in this Table. HIV human immunodeficiency viruses, AIDS acquired immunodeficiency syndrome